ENG

Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals

News

Bird & Bird strengthens Stockholm IP team with new partner Wendela Hårdemark

Mar 04 2025

Read More

Deal

Bird & Bird advises European industry players in European Commission investigation on trade tariffs

Feb 27 2025

Read More

Deal

Bird & Bird advises AgriZeroNZ in its investment in Agteria Biotech

Feb 26 2025

Read More

News

Bird & Bird rolls out Legora AI solution firmwide with a suite of options rooted in client needs

Feb 25 2025

Read More

News

Bird & Bird boosts Japan office with the arrival of Commercial Partner Aya Saito

Feb 24 2025

Read More

Deal

Bird & Bird advises TriMas on its acquisition of GMT’s aerospace business unit

Feb 24 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare